Dr. Mark Scholz is a medical oncologist specializing exclusively in the treatment of prostate cancer, and in this video he answers patients' questions from our KZitem channel about a recent retrospective study claiming that surgery is superior to EBRT in very high-risk patients, whether hormone therapy needs to be initiated 2-months before radiation therapy, if genomic testing can determine whether lymph nodes should be treated with radiation, and how to talk to an oncologist about the possibility of shortening hormone therapy after a negative PSMA PET scan.
0:09 A study was recently published that claimed that surgery was superior to EBRT in very high-risk disease which contradicts other studies from the past. How do you interpret those conclusions?
3:38 "I am a 66-year-old man with Gleason 9 prostate cancer. I have decided on proton therapy, but one doctor is telling me that I need to start hormone therapy 2-months before the proton therapy and another one is telling me it does not matter when I do the hormone therapy. Which is correct?"
5:22 "I have Gleason 8 prostate cancer and I want to know if a genomic test would provide evidence to whether radiation to the pelvic lymph nodes would be advisable without having to do a PSMA PET scan?"
7:16 "How should I talk to my oncologist if I want to shorten my hormone therapy if a PSMA PET scan has not shown any spread outside the prostate gland?"
Don’t know your stage? Take the quiz: Visit www.prostatecancerstaging.org
To learn more about prostate cancer visit www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's KZitem channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
Негізгі бет High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRI
Пікірлер: 40